Compare ASB & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASB | MMED |
|---|---|---|
| Founded | 1861 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.5B |
| IPO Year | 2014 | 2025 |
| Metric | ASB | MMED |
|---|---|---|
| Price | $30.92 | $20.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $29.75 | $22.56 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 04-23-2026 | 06-03-2026 |
| Dividend Yield | ★ 3.45% | N/A |
| EPS Growth | ★ 284.72 | N/A |
| EPS | ★ 1.33 | N/A |
| Revenue | $1,102,756,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | $21.24 | $15.99 |
| Revenue Next Year | $8.86 | $10.00 |
| P/E Ratio | $23.16 | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $23.86 | $10.65 |
| 52 Week High | $32.46 | $20.88 |
| Indicator | ASB | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 58.99 |
| Support Level | $29.92 | $10.68 |
| Resistance Level | $31.77 | $20.88 |
| Average True Range (ATR) | 0.47 | 0.91 |
| MACD | -0.13 | -0.18 |
| Stochastic Oscillator | 28.02 | 53.45 |
Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.